Journal of Clinical Medicine (Feb 2022)

Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma

  • Gao-Jian Su,
  • Jie Gao,
  • Chu-Wei Wu,
  • Jun-Feng Zou,
  • Di Zhang,
  • Dong-Liang Zhu,
  • Jun Liu,
  • Jie-Hua Zhang,
  • Xian-Jian Huang

DOI
https://doi.org/10.3390/jcm11040902
Journal volume & issue
Vol. 11, no. 4
p. 902

Abstract

Read online

Chronic subdural hematoma (CSDH) is a common neurological disease that involves the collection of blood products in the subdural space. The progression of CSDH is an angiogenic and inflammatory process, but the multifactorial mechanisms underlying CSDH are still not fully understood. We aimed to identify one or more factors that may play an important role in the development of CSDH. We enrolled 83 patients with CSDH, including 17 postoperative patients, and analyzed 20 markers in the hematoma fluid and peripheral blood of each patient. Overall differential gene expression was examined to identify the representative markers. The concentration of MMP-8 was significantly lower in the postoperative group than in the preoperative group. The concentration of MMP-9 was significantly higher in the postoperative group than in the preoperative group. These findings indicate that MMP-8 and MMP-9 may play important roles in the pathophysiology of CSDH. Understanding the pathways associated with CSDH may provide insights for improving disease outcomes.

Keywords